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Abstract 
Extended-spectrum beta-lactamases (ESBLs) are plasmid-mediated beta lactamases that are capable of 
hydrolysing beta-lactams except carbapenems and cephamycins. The ESBL types include SHV, TEM and CTX-
M, OXA, PER and VEB-1. The most common ones isolated from clinical specimen are the CTX-M, SHV and 
TEM.  The specific ESBL-producing organisms have different genetic characteristics which mark their 
identification at the molecular level. This work sought to determine the genetic characterization of ESBL-
producing K. pneumoniae and E. coli in Accra. The molecular investigations of the ESBL-coding genes included 
extraction of 100 DNA templates of phenotypic ESBL-producing isolates by boiling method, preparation of the 
PCR reaction mixture using appropriate primers, standard PCR reaction in a thermocycler,   agarose gel 
electrophoresis, bands visualization by ultraviolet trans-illumination and bands photography using a Kodak 
EDAS 290 gel documentation system. The results significantly (p<0.05) indicated that of the 100 ESBL 
producers, 90(90%) possess CTX-M genes and 25(25%) had TEM genes. None of the ESBL producers 
possesses SHV genes. Seventy (70%) of the ESBL producers possess only CTX-M genes and 5(5%) had only 
TEM genes. Twenty (20%) of the isolates had both CTX-M and TEM genes. Of the 100 ESBL phenotypes, 
78(78%) and 2(2%) were positive for CTX-M-1group and CTX-M-9group ESBL genes respectively. Organisms 
producing CTX-M-type ESBL are more prevalent in Accra than other ESBL types. CTX-M-1group producing 
isolates dominated the ESBL phenotypes with CTX-M-15 likely to be the dominate CTX-M-type ESBL. There 
is the need for further studies into the characteristic transmission, pathogenesis, antibiotic resistance expression, 
and infection control of CTX-M-type ESBL and TEM-type ESBL in Accra. 
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1.0 Introduction 
Extended-spectrum beta-lactamases (ESBLs) are plasmid-mediated beta lactamases that are capable of 
hydrolysing beta-lactams except carbapenems and cephamycins. They are inhibited by beta-lactamase inhibitors 
such as clavulanic acid, sulbactam and tazobactam. They have been found in the Enterobacteriaceae and other 
Gram-negative bacilli. ESBL producing isolates are predominantly Klebsiella pneumoniae and Escherichia coli 
(Paterson and Bonomo, 2005). The ESBL types include SHV, TEM and CTX-M, OXA, PER and VEB-1. The 
most common ESBL genes isolated from clinical specimen are the CTX-M, SHV and TEM (Paterson and 
Bonomo, 2005).  It has been observed that the same organism may harbour two or more ESBL genes, which may 
change the antibiotic resistance phenotype (Yamasaki et al., 2003).  
The CTX-M enzymes are replacing SHV and TEM enzymes as the prevalent type of ESBLs in urinary tract 
infections, bloodstream and intra-abdominal infections (Falagas and Karageorgopoulos, 2009). The phylogenic 
study reveals five major groups of acquired CTX-M enzymes (Bonnet, 2004). The CTX-M-1group (Group I) 
includes CTX-M-1, CTX-M-3, CTX-M-10, CTX-M-12, CTX-M-15, CTX-M-22, CTX-M-23, CTX-M-28, CTX-M-29 
CTX-M-30 and CTX-M-68. The CTX-M-2group (Group II) includes CTX-M-2, CTX-M-4, CTX-M-5, CTX-M-6, 
CTX-M-7 and CTX-M-20. The CTX-M-8group (Group III) includes one plasmid-mediated member, CTX-M-8. 
The CTX-M-9group (Group IV) includes nine plasmid-mediated enzymes (CTX-M-9, CTX-M-13, CTX-M-14, 
CTX-M-16, CTX-M-17, CTX-M-19, CTX-M-21, CTX-M-24 and CTX-M-27). The CTX-M-25group (Group V) 
includes the CTX-M-25 and CTX-M-26 enzymes (Bonnet, 2004). The CTX-M-15 and CTX-M-14 seems to be the 
most widespread globally, while many of the other CTX-M ESBLs tend to be more limited in their distribution 
(Heffernan et al., 2007).  
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The specific ESBL-producing organisms have different genetic characteristics which mark their identification at 
the molecular level. This genetic diversity in the various ESBL-producing organisms may reflect characteristic 
differences in relation to pathogenesis, antibiotic resistance expression, response to therapy, transmission and 
infection control. Genetic characterization of ESBL-producing organisms is also essential for epidemiological 
use. This work seeks to determine the genetic characterization of ESBL-producing K. pneumoniae and E. coli in 
Accra.  
 
2.0 Materials and Methods 
2.1 Materials 
Glycerol broth, blood agar and MacConkey agar were prepared according to manufacturers’ guidelines. Vitek 2 
Compact System (bioMérieux, Marcy I’Etoile, France) was used to identify the isolates and determine ESBL 
phenotypes. Water bath was used to heat the colony suspension and centrifuge was used to spin the suspension to 
extract the bacteria DNA. BIOR GenePro thermocycler was used to perform the polymerase chain reaction 
(PCR) under controlled reaction conditions with specific primers.  PCR products were used to perform agarose 
gel electrophoresis with 1X TAE buffer, 2% agarose gel and 0.5µg/ml ethidium bromide at 120V for 45minutes. 
The bands on the gels were visualized by ultraviolet trans-illumination and photographed using a Kodak EDAS 
290 gel documentation system.  
2.2 Study Sites 
Lactose fermenting bacterial isolates were collected from the Central Laboratory of the Korle Bu Teaching 
Hospital (KBTH) and Advent Clinical Laboratories; both in the Accra Metropolis, Ghana. The PCR was 
performed at the molecular biology laboratory of the School of Allied Health Sciences, University of Ghana and 
the bands on the gels were visualized and photographed at the molecular biology laboratory of the Microbiology 
Department of University of Ghana Medical School.  
 
2.3 Sample Size 
A sample size of 100 DNA templates extracted from ESBL- producing K. pneumoniae and E. coli isolates. 
 
2.4 Inclusion Criteria 
Non-duplicate pure cultures of ESBL-producing K. pneumoniae and E. coli isolates were used in the work. 
 
2.5 Exclusion Criteria 
All isolates not confirmed as ESBL-producing K. pneumoniae and E. coli were excluded. 
 
2.6 Determination of ESBL Phenotypes  
The isolates were identified as K. pneumoniae and E. coli based on their gram stain reaction and biochemical 
reaction characteristics in the ID test cards wells using Vitek 2 system (bioMérieux, Marcy I’Etoile, France).  
The Vitek 2 system was used to concurrently determine the ESBL phenotypes based on the simultaneous 
assessment of the inhibitory effects of cefotaxime, ceftazidime and cefepime, alone and in the presence of 
clavulanic acid in accordance with the CLSI. 
 
2.7 Molecular Analysis of ESBL-coding Genes 
The molecular investigations of the ESBL-coding genes included extraction of DNA templates of phenotypic 
ESBL-producing isolates by boiling method, preparation of the PCR reaction mixture using appropriate primers, 
standard PCR reaction in a thermocycler,   agarose gel electrophoresis, bands visualization by ultraviolet trans-
illumination and bands photography using a Kodak EDAS 290 gel documentation system. 
 
2.7.1 Genomic DNA Extraction of K. pneumoniae and E. coli 
DNA template was extracted by a simple boiling method (Heffernan et al., 2007). A loopful of bacterial colony 
was picked from each isolate and suspended in 100µl of double distilled H2O in Eppendorf tube. The DNA 
suspension was incubated at 99°C for 5 minutes and snapped cold on ice for 10 minutes. The cell lysate was then 
centrifuged briefly at high speed (12.000 rpm for 3 min), and the supernatant containing genomic DNA was 
transferred into sterile Eppendorf and 5µl of the supernatant was used for PCR reaction. The extracted DNA was 
stored at -21°C until required for PCR. 
 
2.7.2 PCR Detection of ESBL-encoding Gene 
PCR of ESBL-encoding genes was carried out using BIOER GenePro thermocycler. A typical 25µl PCR 
reaction mixture for a primer set was prepared as shown in table 3. The primers used were already published 
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primers as shown in table 1 for CTX-M, TEM and SHV genes and their corresponding PCR conditions (table 2). 
Further PCRs using the primers for CTX-M-1group and CTX-M-9group were performed with isolates that were 
positive with the universal CTX-M primers (Heffernan et al., 2007). Sterile distilled water as negative controls 
were included in each round of PCR. 
 
Table 1: Primers used for the detection of ESBL genes (Heffernan et al., 2007) 
Primer Name Sequence (5'-3') Target Gene Size (bp)  
SHV-F GCCGGGTTATTCTTATTTGTCCG SHV 1007 
SHV-R ATGCCGCCGCCAGTCA   
TEM-F GTATCCGCTCATGAGACAATA TEM 966 
TEM-R TCTAAAGTATATATGAGTAAAC   
CTX-M-F TTTGCGATGTGCAGTACCAGTAA CTX-M 590 
CTX-M-R CGATATCGTTGGTGGTGCCATA   
CTX-M-1-F CCCATGGTTAAAAAATCACTG CTX-M-1 group   891 
CTX-M-1-R  CCGTTTCCGCTATTACAAAC   
CTX-M-9-F GTGACAAAGAGAGTGCAACGG CTX-M-9 group 857 
CTX-M-9-R  ATGATTCTCGCCGCTGAAGCC   
 
  Table 2: PCR conditions used for the detection of ESBL genes (Heffernan et al., 2007) 
Target Gene PCR Conditions 
SHV Initial denaturation for 5min at 94ºC 1 cycle 
 94ºC for 30s 35 cycles 
 68ºC for 30s 
 72ºC for 60s 
 Final extension at 72ºC for 7min 1 cycle 
TEM Initial denaturation for 5min at 94ºC 1 cycle 
 94ºC for 60s 35 cycles 
 55ºC for 30s 
 72ºC for 60s 
 Final extension at 72ºC for 10min 1 cycle 
CTX-M Initial denaturation for 5min at 94ºC 1 cycle 
 94ºC for 30s 30 cycles 
 60ºC for 30s 
 72ºC for 60s 
 Final extension at 72ºC for 7min 1 cycle 
CTX-M-1group Initial denaturation for 10min at 94ºC 1 cycle 
 94ºC for 60s 30 cycles 
 55ºC for 60s 
 72ºC for 2mins 
 Final extension at 72ºC for 5min 1 cycle 
CTX-M-9group  Initial denaturation for 10min at 94ºC 1 cycle 
 94ºC for 30s 25 cycles 
 55ºC for 30s 
 72ºC for 60s 
 Final extension at 72ºC for 10min 1 cycle 
 
Table 3: PCR reaction mixture 
Reagent Volume (µl) Final concentration 
Nuclease-free water  16.175 - 
10X PCR buffer + MgCl2 2.5 1X 
10mM DNTP mix 0.4 200 µM each 
10µM forward primer 0.4 0.2µM 
10µM reverse primer 0.4 0.2µM 
5U/µl Taq polymerase 0.125 0.5U 
Template DNA 5 (≤1 µg/reaction) 
TOTAL volume 25  
 
 
2.7.3 Agarose Gel Electrophoresis 
The buffer (1XTAE buffer) was prepared and subsequently used to prepare 2% agarose gel. The suspension was 
boiled in a microwave for 2 minutes. The molten agarose was allowed to cool to 60°C and stained with 3µl of 
0.5µg/ml ethidium bromide (which absorbs invisible UV light and transmits the energy as visible orange light). 
A comb was inserted into the slots of the casting tray and the molten agarose was poured into the tray. The gel 
was allowed to solidify for 20 minutes to form the wells. The 1XTAE buffer was poured into the gel tank to 
barely submerge the gel. Two microliter (2µl) of 10X blue gel loading dye (which gives colour and density to the 
samples to make it easy to load into the wells and monitor the progress of the gel) was added to 10µl of each 
PCR product and loaded into the wells. The 100bp DNA ladder was loaded into well 1. The gel was 
electrophoresed at 120V for 45 minutes using either a midi or a maxi gel system. The bands on the gels were 
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visualized by ultraviolet trans-illumination and photographed using a Kodak EDAS 290 gel documentation 
system. The sizes of the PCR products were estimated by comparison with the mobility of a 100bp molecular 
weight ladder that was ran alongside experimental samples in the gel. 
2.8 Statistical Analyses 
The data from the work was collated and statistically analysed using using the chi-square test. P values < 0.05 
were considered significant. 
 
3.0 Results 
Of the 100 ESBL producers, 90% possessed CTX-M genes with bands amplicon size of 590bp as in plate 1 and 
25% had TEM genes with bands amplicon size of 966bp as shown in plate 2. None of the ESBL producers 
possessed SHV genes as indicated in table 4. Seventy percent (70%) of the ESBL producers possessed only 
CTX-M genes and 5% had only TEM genes. Twenty percent (20%) of the isolates had both CTX-M and TEM 
genes. Of the 100 ESBL phenotypes, 78% and 2% were positive for CTX-M-1group and CTX-M-9group ESBL 
genes respectively as demonstrated in table 5. CTX-M-1group ESBL genes with bands amplicon size of 891bp 
and CTX-M-9group with band amplicon size of 857bp are indicated in plate 3 and plate 4 respectively.    
    Table 4: Occurrence of ESBL-coding genes in K. pneumoniae and E. coli Isolates by  
                   Polymerase Chain Reaction  
  
                                                                                             Number (%) 
       ESBL-genes                                                         Isolates (n= 100) 
      CTX-M                                                                             90(90)              
      TEM                                                                                  25(25) 
       SHV                                                                                    0(0) 
      CTX-M Only                                                                     70(70) 
      TEM Only                                   5(5) 
      CTX-M and TEM                                                              20(20) 
      Neither CTX-M or TEM                                                      5(5) 
   
       
 
    Table 5: Occurrence of CTX-M-group ESBL coding genes in K. pneumoniae and E. coli  
                    Isolates by Polymerase Chain Reaction 
  
                                                                                              Number (%) 
       ESBL-genes                                                           Isolates (n= 100) 
      CTX-M-1group                                                                 78(78) 
       
      CTX-M-9group                                                                   2(2)  
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                        M    1      2       3       4     5      6        7       8     9     10     11     12     13    14   15 
                     
                   Plate 1 Representative agarose gel electrophoregram of PCR products (band size  
                   590bp) of ESBL gene CTX-M  
                   Lane M=100bp marker; Lanes 1-6=PCR positive CTX-M; Lanes 7 and 9 = PCR  
                   negative CTX-M; Lanes 8, 10-15 = PCR positive  
    
                                     M       1         2           3         4          5         6           7         8         9 
                                 
                            Plate 2 Representative agarose gel electrophoregram of PCR 
                            products (band size 966bp) of ESBL gene TEM Lane M=100bp marker;  
                            Lanes 1-9 =PCR positive TEM 
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                  M    1     2       3        4      5      6       7       8       9      10     11     12     13   14    15                                
                      
                          Plate 3 Representative agarose gel electrophoregram of PCR products  
                          (band size 891bp) of ESBL gene CTX-M-G1 
                           Lane M=100bp marker; Lanes 1-6=PCR positive CTX-M-G1; Lanes 7  
                          and 8 = PCR negative CTX-M-G1; Lanes 9-15 = PCR positive CTX-M-G1          
    
 
                    M      1      2       3       4        5        6        7        8        9     10      11      12    
                  
                    Plate 4 Representative agarose gel electrophoregram of PCR products (band size  
                    857bp) of ESBL gene CTX-M-G9 
                    Lane M=100bp marker; Lanes 7 and 9 =PCR positive CTX-M-G9; Lanes 1-6  
                    and 10-12 = PCR negative CTX-M-G9 
 
4.0 Discussion 
CTX-M-type, TEM-type and SHV-type ESBLs are the main types of ESBL produced by bacteria. Some 
researchers have suggested that CTX-M-type ESBLs are now the most frequent ESBL type worldwide as 
compared to SHV and TEM-type ESBLs (Paterson and Bonomo, 2005). In this study 90% isolates produced 
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CTX-M-type ESBL confirming that CTX-M is the dominant ESBL-type in Accra as it is in the rest of world 
(Falagas and Karageorgopoulos, 2009). 
The percentage of isolates producing CTX-M-type ESBL in this present study is consistent with the 
study in Kumasi, Ghana by Feglo (2013) who reported 94.4% CTX-M-type ESBL. However, while Feglo (2013) 
reported that 64.5% of the ESBL isolates possess two genes and 29.9% possess three genes; only 20% of ESBL 
isolates in this present study had two genes and none possessed three ESBL genes. In a study in Southwest 
Nigeria, 30 selected multidrug-resistant K. pneumoniae strains isolated from patients with urinary tract infections 
showed 57% CTX-M enzymes (Olysegun et al., 2006) which were slightly lower than the 87.1% of CTX-M 
ESBLs observed in K. pneumoniae strains in this study. Reports from Indonesia confirmed the high prevalence 
(94.5%) of CTX-M-type ESBL (Severin et al., 2010). This was also corroborated by Tham and others (2010) 
who observed that 90% ESBL-positive genes were of CTX-M ESBL-type. This study was consistent with the 
finding by Heffernan and colleagues (2007) in New Zealand who observed that 96% E. coli and K. pneumoniae 
isolates produced CTX-M ESBL genes which is also corroborated by a study done in Canada (Pitout et al., 
2007). So in this study, Ghana joins North America, South America, Western Europe, Asia and other African 
nations with high prevalent CTX-M-ESBL producers (Paterson and Bonomo, 2005). 
This study has shown that 78% of the CTX-M-type ESBLs were CTX-M-1group with 2% belonging to 
CTX-M-9group corroborating the study of Tham and colleagues in 2010 who reported that CTX-M-1group was 
prevalent followed by the CTX-M-9group as do the conclusions of Heffernan and colleagues who also showed 
that CTX-M-1group (CTX-M-15) and CTX-M-9group (CTX-M-14) seem to be the most widespread (Heffernan 
et al., 2007). However, this study is at variance with the work of Pitout and colleagues in 2007 who found 48% 
and 37% CTX-M-1group and CTX-M-9group respectively.  
The high prevalence of CTX-M-1group ESBL observed in this study confirms the studies in other parts 
of Africa. In Tanzania, Blomberg and colleagues (2005) discovered the presence of CTX-M-1group (CTX-M-
15) ESBL-producing organism for the first time in Africa. In Tunisia, 43 of 47 isolates showed CTX-M-1group 
(CTX-M-15) and 2 CTX-M-9group (CTX-M-14) (Elhani et al., 2010). This consensus of CTX-M ESBL genes 
dominating the ESBL types was contradicted by the study of Feglo (2013) in Kumasi, Ghana which reported 
TEM-type ESBL as the dominating ESBL gene.  
In this study 25% of the bacterial isolates produced TEM-type ESBL, a result which is lower as 
reported in Canada (Pitout et al., 2007) and New Zealand (Heffernan et al., 2007). Furthermore, Severin and 
colleagues (2010) in a study of 73 ESBL-positive E. coli and 72 K. pneumoniae strains, TEM-type ESBLs were 
not detected in any of the isolates. Interestingly Feglo in 2013, reported a high prevalent of 96.2% of TEM-type 
ESBL phenotypes in a study in Kumasi in contrast to the findings of this study and other reports.  
Regarding SHV-type ESBL, none was seen in 100 strains of ESBL phenotypes in this study confirming 
a study in Algiers by Ramdani-Bouguessa and colleagues in 2006. Low rates were reported in New Zealand 
(Heffernan et al., 2007) and North Lebanon (Sana et al., 2011) which contradicts findings in this study. 
However, higher rates of 32.5% SHV-type ESBL were reported by Feglo (2013) in Kumasi contradicting this 
work also in Ghana, 38.7% in Cameroon Gangoué-Piéboji et al., 2005) while Jones and others also reported that 
SHV genes were found in 41% and 28% of the ESBL-positive K. pneumoniae and E. coli isolates respectively 
(Jones et al., 2009) in contrast to this study.  
 
5.0 Conclusion 
The findings of this work suggest that organisms producing CTX-M-type ESBL are more prevalent in Accra 
than other ESBL types. The present study indicated that the CTX-M-1group producing isolates dominated the 
ESBL phenotypes and CTX-M-15 may be the dominant CTX-M-type ESBL. There is the need for further 
studies into the characteristic transmission, pathogenesis, antibiotic resistance expression, response to therapy 
and infection control of CTX-M-type ESBL and TEM-type ESBL in Accra. 
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